Article citationsMore >>

Kubysheva N, Boldina M, Eliseeva T, et al. Relationship of serum levels of IL-17, IL-18, TNF-α, and lung function parameters in patients with COPD, asthma-COPD overlap, and bronchial asthma. Mediat Inflamm, 2020, 2020(4): 4652898-908.

has been cited by the following article:

Article

The Clinical Effect and Mechanism of Kechuan Guben Pills for Blood Stasis Syndrome of COPD in Stable Stage

1Department of Respiratory and Critical Care Medicine, Linyi TCM Hospital, Linyi 276003, China

2Institute of Integrate Medicine, Qingdao University Medical College, Qingdao 266021, China

3Department of Neurosurgery, Jinan Jiyang District People’s Hospital, Jinan 251400, China

4Department of Medical Imaging, Linyi Municipal People's Hospital, Linyi 276003, China


American Journal of Medical Sciences and Medicine. 2024, Vol. 12 No. 4, 80-84
DOI: 10.12691/ajmsm-12-4-1
Copyright © 2024 Science and Education Publishing

Cite this paper:
Xun-qing Ni, Qin-shuai Ni, Wen-cai Song, Feng Gao, Xin-wei Zhang. The Clinical Effect and Mechanism of Kechuan Guben Pills for Blood Stasis Syndrome of COPD in Stable Stage. American Journal of Medical Sciences and Medicine. 2024; 12(4):80-84. doi: 10.12691/ajmsm-12-4-1.

Correspondence to: Xin-wei  Zhang, Department of Medical Imaging, Linyi Municipal People's Hospital, Linyi 276003, China. Email: 1109502219@qq.com

Abstract

Objective: To observe the therapeutic efficacy and possible mechanism of Kechuan Guben Pills (KGP) in patients with blood stasis syndrome of COPD in stable stage. Methods: All patients diagnosed with blood stasis syndrome of COPD in stable stage hospitalized in Department of Respiratory and Critical Care Medicine, Linyi TCM Hospital from June 2021 to January 2023, were selected and randomly divided into control group received Budesonide 2 puffs, twice a day and treatment group given KGP on the basis of control group, 9 g, twice a day for six months. The traditional Chinese medicine (TCM) syndrome scores of patients were collected according to TCM Syndrome Diagnosis Criteria of Chronic Obstructive Pulmonary Diseaseand and the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive protein (hs-CRP), transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF) were determined by immunofluorescence assay and latex enhanced immunoscattering turbidimetric assay. Results: The taotal effective rate of patients in the treatment group (96.97%) was significantly higher than that in the control group (82.86%), P < 0.05. The TCM syndrome scores of patients in the treatment group showed significant improvement compared to the control group (P < 0.01). The serum levels of IL-6, TNF-α, hs-CRP, TGF-β and VEGF in the treatment group showed significantly better than those in the treatment group (P < 0.01). Conclusion: KGP could significantly improve TCM symptoms of patients with blood stasis syndrome of COPD in stable stage by inhibiting the expressions of inflammatory factors and regulating the collagen fiber deposition related factors in the extracellular matrix.

Keywords